Marty
Well-known member
Exanta(ximelagatran) has passed its first test with orthopedic patients. Its a direct thrombin inhibitor so its not affected by Vitamin K and other drugs.It doesn't require an injection like Lovenox and doesn't require regular monitoring of the prothrombin time.It goes into one more clinical trials for orthopedic patients and then later it must be clinically tested in atrial fib and valve patients. How soon will most of us be able to take it if all goes well? I'm guessing but I'd say 2004. Another drug in trials is Arixtra(fonda parinux sodium).It works differently than Exanta in the clotting cascade but also seems to have a wide safety range and not effected by Vitamin K and other drugs. I'm hoping one or both of these drugs gets FDA approval before my Coaguchek wears out.